AAAAAA
Results: 1-25/56
Authors:
PUJOL JL
BOHER JM
QUANTIN X
PARRAT E
GRENIER J
DAURES JP
Citation: Jl. Pujol et al., MARKOV MODEL AND MARKER OF NONSMALL CELL LUNG-CANCER - ASSESSING THE INFLUENCE OF REVERSIBLE SERUM CYFRA 21-1 LEVELS ON PROGNOSIS, Annals of oncology, 9, 1998, pp. 441-441
Authors:
REBATTU P
PUJOL JL
ARDIET C
QUENTIN X
DROZ JP
DUMORTIER A
KHIAL F
SCHULLER MP
Citation: P. Rebattu et al., COMBINATION OF DOCETAXEL (DTX) AND GEMCITABINE (G) IN PATIENTS WITH INOPERABLE OR METASTATIC NONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-I STUDY, Annals of oncology, 9, 1998, pp. 361-361
Authors:
QUANTIN X
GODARD P
MICHEL FB
PUJOL JL
Citation: X. Quantin et al., NEW CYTOTOXICS IN THE TREATMENT OF ASTHMA AND BRONCHIAL-CANCER, Revue des maladies respiratoires, 15(5), 1998, pp. 597-612
Authors:
PUJOL JL
BOHER JM
GRENIER J
QUANTIN X
SAFFONT L
DAURES JP
Citation: Jl. Pujol et al., NEURON-SPECIFIC ENOLASE (NSE) IN THE SURVEILLANCE OF SMALL-CELL CANCERS - AN ASSESSMENT OF THE PROGNOSTIC INFORMATION USING MARKOVS MODEL, Revue des maladies respiratoires, 15(4), 1998, pp. 519-525
Authors:
PUJOL JL
DEMOLY P
QUANTIN X
SIMONY J
PARRAT E
LEHMANN M
DAURES JP
JOLIMOY G
GRENIER J
PAU B
GODARD P
Citation: Jl. Pujol et al., BIOLOGICAL PERSPECTIVES, Revue des maladies respiratoires, 15(3BIS), 1998, pp. 428-440
Authors:
RAY P
QUANTIN X
GRENIER J
PUJOL JL
Citation: P. Ray et al., PREDICTIVE FACTORS OF TUMOR RESPONSE AND PROGNOSTIC FACTORS OF SURVIVAL DURING LUNG-CANCER CHEMOTHERAPY, Cancer detection and prevention, 22(4), 1998, pp. 293-304
Authors:
MATTSON K
LECHEVALIER T
BOSQUEE L
PUJOL JL
CULINE S
DABOUIS G
LEGROUMELLEC A
STUPP R
BOYER R
BERILLE J
Citation: K. Mattson et al., INTERIM RESULTS OF A PHASE-II STUDY OF DOCETAXEL (TAXOTERE(R)) IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) ON 204 CHEMOTHERAPY NAIVE OR PRETREATED PATIENTS, European journal of cancer, 33, 1997, pp. 1036-1036
Authors:
QUANTIN X
PUJOL JL
PARIS A
REMESAUMON M
KHIAL F
GODARD P
MICHEL FB
Citation: X. Quantin et al., CONCOMITANT BRAIN RADIOTHERAPY AND HIGH-DOSE IFOSFAMIDE IN BRAIN RELAPSES OF LUNG-CANCER, Annals of oncology, 8(9), 1997, pp. 911-913
Authors:
PUJOL JL
Citation: Jl. Pujol, CYFRA-21-1, Revue des maladies respiratoires, 14, 1997, pp. 31-36
Authors:
PUJOL JL
DOUILLARD JY
RIVIERE A
QUOIX E
LAGRANGE JL
BERTHAUD P
BARDONNETCOMTE M
POLIN V
GAUTIER V
MILLERON B
CHOMY F
CHOMY P
SPAETH D
LECHEVALIER T
Citation: Jl. Pujol et al., DOSE-INTENSITY OF A 4-DRUG CHEMOTHERAPY REGIMEN WITH OR WITHOUT RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A MULTICENTER RANDOMIZED PHASE-IIISTUDY, Journal of clinical oncology, 15(5), 1997, pp. 2082-2089
Authors:
QUANTIN X
PUJOL JL
LEHMANN M
SIMONY J
SERRE I
MICHEL FB
Citation: X. Quantin et al., IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN AND PROGNOSIS OF SURGICALLY RESECTED NON-SMALL-CELL LUNG-CANCER, Cancer detection and prevention, 21(5), 1997, pp. 418-425
Authors:
MICHEL FB
PUJOL JL
Citation: Fb. Michel et Jl. Pujol, LUNG-CANCER - FROM EPIDEMIOLOGY TO MANAGEMENT, La Semaine des hopitaux de Paris, 73(27-28), 1997, pp. 879-889
Authors:
DEMOLY P
BOUSQUET J
PUJOL JL
MICHEL FB
Citation: P. Demoly et al., RECENT ASPECTS ON THE GENETICS OF RESPIRA TORY ALLERGIC DISEASES, Bulletin de l'Academie nationale de medecine, 181(8), 1997, pp. 1585-1595
Authors:
PUJOL JL
GRENIER J
PARRAT E
LEHMANN M
LAFONTAINE T
QUANTIN X
MICHEL FB
Citation: Jl. Pujol et al., CYTOKERATINS AS SERUM MARKERS IN LUNG-CANCER - A COMPARISON OF CYFRA 21-1 AND TPS, American journal of respiratory and critical care medicine, 154(3), 1996, pp. 725-733
Authors:
PUJOL JL
PARRAT E
LEHMANN M
GAUTIER V
DAURES JP
MICHEL FB
GODARD P
Citation: Jl. Pujol et al., LUNG-CANCER CHEMOTHERAPY - RESPONSE SURVIVAL RELATIONSHIP DEPENDS ON THE METHOD OF CHEST TUMOR RESPONSE EVALUATION, American journal of respiratory and critical care medicine, 153(1), 1996, pp. 243-249
Authors:
GAUTIER V
REDIER H
PUJOL JL
BOUSQUET J
PROUDHON H
MICHEL C
DAURES JP
MICHEL FB
GODARD P
Citation: V. Gautier et al., COMPARISON OF AN EXPERT-SYSTEM WITH OTHER CLINICAL SCORES FOR THE EVALUATION OF SEVERITY OF ASTHMA, The European respiratory journal, 9(1), 1996, pp. 58-64
Authors:
PUJOL JL
QUANTIN X
MICHEL FB
Citation: Jl. Pujol et al., CELL-GROWTH FACTORS IN THE TREATMENT OF B RONCHOGENIC CANCER, Revue des maladies respiratoires, 13(4), 1996, pp. 335-338
Authors:
DEMOLY P
MATHIEU M
PUJOL JL
BOUSQUET J
GODARD P
MICHEL FB
Citation: P. Demoly et al., VECTORS FOR GENETIC TRANSFER - APPLICATIO NS IN THORACIC MEDICINE, Revue des maladies respiratoires, 13(3), 1996, pp. 251-257
Authors:
GAUTIER V
PUJOL JL
ZINAI A
MICHEL FB
Citation: V. Gautier et al., R-METHUG-CSF SUPPORT TO IFOSFAMIDE, CISPLATIN, ETOPOSIDE CHEMOTHERAPYIN NON-SMALL-CELL LUNG-CANCER, Lung cancer, 14(2-3), 1996, pp. 343-351
Authors:
LECHEVALIER T
BRISGAND D
PUJOL JL
DOUILLARD JY
MONNIER A
RIVIERE A
CHOMY P
LEGROUMELLEC A
RUFFIE P
GOTTFRIED M
GASPARD MH
CHEVREAU C
ALBEROLA V
CIGOLARI S
BESSON F
MARTINEZ A
BESENVAL M
BERTHAUD P
TURSZ T
Citation: T. Lechevalier et al., RANDOMIZED STUDY OF NAVELBINE(R) AND CISP LATIN VERSUS VINDESINE AND CISPLATIN VERSUS NAVELBINE(R) ALONE IN 612 PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), Bulletin du cancer, 83(5), 1996, pp. 385-394
Authors:
PUJOL JL
SIMONY J
JOLIMOY G
JAFFUEL D
DEMOLY P
QUANTIN X
MARTYANE C
BOHER JM
CHARPENTIER R
MICHEL FB
Citation: Jl. Pujol et al., HYPODIPLOIDY, KI-67 GROWTH FRACTION AND PROGNOSIS OF SURGICALLY RESECTED LUNG CANCERS, British Journal of Cancer, 74(6), 1996, pp. 964-970
Authors:
MICHEL FB
PUJOL JL
Citation: Fb. Michel et Jl. Pujol, LUNG-CANCER - FROM EPIDEMIOLOGY TO TREATM ENT, Bulletin de l'Academie nationale de medecine, 180(7), 1996, pp. 1585-1607
Authors:
PUJOL JL
DOUILLARD JY
RIVIERE A
POUDENX M
QUOIX E
SPAETH D
CHOMY P
LAFITTE JJ
MONNIER A
MILLERON B
BERTHAUD P
LECHEVALIER T
Citation: Jl. Pujol et al., DOSE-INTENSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER (SCLC) - PRELIMINARY-RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 78-78
Authors:
PUJOL JL
LECHEVALIER T
DOUILLARD JY
RIVIERE A
CHOMY P
MONIER A
MAHJOUBI M
Citation: Jl. Pujol et al., CPT-11 (IRINOTECAN) IN PRETREATED SMALL-CELL LUNG-CANCER (SCLC) - A PHASE-II STUDY IN PATIENTS PROGRESSING AFTER A FIRST RESPONSE (PRELIMINARY-RESULTS), European journal of cancer, 31A, 1995, pp. 92-92
Authors:
DOUILLARD JY
RIVIERE A
SPAETH D
CHOMY P
PUJOL JL
Citation: Jy. Douillard et al., A PHASE-II STUDY OF CPT-11 (IRINOTECAN 350 MG M(2) EVERY 3 WEEKS) IN UNTREATED NON-SMALL-CELL LUNG CARCINOMAS/, European journal of cancer, 31A, 1995, pp. 1095-1095